# Topical Insulin for Glaucoma

> **NCT05206877** · PHASE1 · RECRUITING · sponsor: **Stanford University** · enrollment: 52 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** Insulin, 4 units
- **DRUG:** Insulin, 20 units
- **DRUG:** insulin, 4 units twice daily
- **DRUG:** insulin, 20 units twice daily
- **DRUG:** insulin, 4 units three times daily
- **DRUG:** insulin, 20 units three times daily

## Key facts

- **NCT ID:** NCT05206877
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2025-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05206877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05206877, "Topical Insulin for Glaucoma". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT05206877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*